医疗

最大限度利用机遇

我们与处于全球医疗革命前沿的企业家和投资者密切合作。我们将深入的行业知识与技术能力相结合,使我们能帮助企业和投资者在寻求巩固和发展其市场地位时,充分利用整个行业的巨大机遇。

人口老龄化、技术变革以及人们对医疗保健产品和服务的需求增加,所有这些为健康和社会护理、医疗设备、生命科学、生物科学和医药市场创造了前所未有的机遇。我们的工作是帮助客户最大限度地利用这些机遇。

< >

我们的最新交易

Clearwater在领导世界各地候选人参与过程中表现非常专业。

Luc Bertholat,Naxicap Partners合伙人

Our 医疗 Team

该团队很快就为我们找到合适的合作伙伴,并借助他们与买方的良好关系协助谈判,达成了实现我们目标的交易。
Dan Smart, CEO, Proclinical

凭借深厚的知识和技术能力,我们的医疗团队在提供量身定制的解决方案方面一直表现优异。

查看我们的团队

Over 65

completed deals

in the last 5 years

€9.4bn

deal value

over the last 5 years

Over 40%

deals involved PE

in the last 5 years

见解

  • Contract Commercialisation Market (CCOs)

    CCOs offer a broad range of commercialisation services to their customers, typically focussed on preparing new products for launch and maximising sales post approval.

    阅读更多
  • Contract Development and Manufacturing Market (CDMOs)

    As innovator pipelines have deepened and the complexities of developing and manufacturing more recent generations of pharma (including biologics) have increased, the need to simplify manufacturing operations and reduce operating expenditure has led to the emergence of the CDMO industry.

    阅读更多
  • Contract Research Organisations (CROs)

    CROs are constantly expanding their addressable markets by broadening their service offerings, capturing an increasing share of pharma R&D expenditure. Investment in technology and big data will continue to play an important role in the expansion of the CRO sub-sector.

    阅读更多